{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:01:08Z","timestamp":1793307668670,"version":"4.5.0"},"reference-count":62,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0127","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:03:17Z","timestamp":1727344997000},"source":"Crossref","is-referenced-by-count":18,"title":["Invasive group A streptococcal infections in Europe after the COVID-19 pandemic"],"prefix":"10.3238","author":[{"given":"Eva","family":"Goldberg-Bockhorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Furitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"10.3238\/arztebl.m2024.0127_ref1","unstructured":"UK Health Security Agency (UKHSA): Group A streptococcal infections: report on seasonal activity in England, 2022 to 2023. 2022. www.gov.uk\/government\/publications\/group-a-streptococcal-infections-activity- during-the-2022-to-2023-season\/group-a-streptococcal- infections-report-on-seasonal-activity-in-england-2022-to-2023 (last accessed on 17 December 2023)."},{"key":"10.3238\/arztebl.m2024.0127_ref2","unstructured":"World Health Organization (WHO): Disease outbreak news: Increased incidence of scarlet fever and invasive group A streptococcus infection—multi-country. 2022. www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON429 (last accessed on 22 December 2023)."},{"key":"10.3238\/arztebl.m2024.0127_ref3","unstructured":"European Centre for Disease Prevention and Control (ECDC): Increase in invasive group A streptococcal infections among children in Europe, including fatalities. European Centre for Disease Prevention and Control 2022. www.ecdc.europa.eu\/en\/news-events\/increase-invasive-group-streptococcal-infections-among-children-europe-including (last accessed on 22 December 2023)."},{"key":"10.3238\/arztebl.m2024.0127_ref4","unstructured":"Robert Koch Institut (RKI): Update: Anstieg bakterieller Infektionen durch Gruppe-A-Streptokokken, Pneumokokken und Haemophilus influenzae in Deutschland seit Ende 2022. Vol. 8, Epidemiologisches Bulletin. 2023; 45. www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2023\/Ausgaben\/08_23.pdf?__blob=publicationFile (last accessed on 19 August 2023)."},{"key":"10.3238\/arztebl.m2024.0127_ref5","doi-asserted-by":"crossref","unstructured":"Steer AC, Lamagni T, Curtis N, Carapetis JR: Invasive group A streptococcal disease: epidemiology, pathogenesis and management. Drugs 2012; 72: 1213–27.","DOI":"10.2165\/11634180-000000000-00000"},{"key":"10.3238\/arztebl.m2024.0127_ref6","doi-asserted-by":"crossref","unstructured":"Oh KB, Doherty TM, Vetter V, Bonanni P: Lifting non-pharmaceutical interventions following the COVID-19 pandemic—the quiet before the storm? Expert Rev Vaccines 2022; 21: 1541–53.","DOI":"10.1080\/14760584.2022.2117693"},{"key":"10.3238\/arztebl.m2024.0127_ref7","unstructured":"Shaw D, Abad R, Amin-Chowdhury Z, et al.: Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS consortium. Lancet Digit Health 2023; 5: e582–93."},{"key":"10.3238\/arztebl.m2024.0127_ref8","doi-asserted-by":"crossref","unstructured":"Amarsy R, Fournier S, Trystram D, et al.: Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: a time-series analysis in Paris region. Am J Infect Control 2023; 51: 475–7.","DOI":"10.1016\/j.ajic.2022.09.002"},{"key":"10.3238\/arztebl.m2024.0127_ref9","doi-asserted-by":"crossref","unstructured":"Chow EJ, Uyeki TM, Chu HY: The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023; 21: 195–210.","DOI":"10.1038\/s41579-022-00807-9"},{"key":"10.3238\/arztebl.m2024.0127_ref10","doi-asserted-by":"crossref","unstructured":"Johannesen TB, Munkstrup C, Edslev SM, et al.: Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Euro Surveill 2023; 28: 2300291.","DOI":"10.2807\/1560-7917.ES.2023.28.26.2300291"},{"key":"10.3238\/arztebl.m2024.0127_ref11","doi-asserted-by":"crossref","unstructured":"de Gier B, Marchal N, de Beer-Schuurman I, et al.: Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Euro Surveill 2023; 28: 2200941.","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200941"},{"key":"10.3238\/arztebl.m2024.0127_ref12","doi-asserted-by":"crossref","unstructured":"Holdstock V, Twynam-Perkins J, Bradnock T, et al.: National case series of group A Streptococcus pleural empyema in children: clinical and microbiological features. Lancet Infect Dis 2023; 23: 154–6.","DOI":"10.1016\/S1473-3099(23)00008-7"},{"key":"10.3238\/arztebl.m2024.0127_ref13","doi-asserted-by":"crossref","unstructured":"Nielsen H, Storgaard M, Helweg-Larsen J, et al.: Group A streptococcus meningitis in adults, Denmark. Emerg Infect Dis 2023; 29: 1937–9.","DOI":"10.3201\/eid2909.230627"},{"key":"10.3238\/arztebl.m2024.0127_ref14","doi-asserted-by":"crossref","unstructured":"Rodriguez-Ruiz JP, Lin Q, Lammens C, et al.: Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1UK, Belgium, May 2022 to August 2023. Euro Surveill 2023; 28: 2300422.","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300422"},{"key":"10.3238\/arztebl.m2024.0127_ref15","doi-asserted-by":"crossref","unstructured":"Gouveia C, Paula Bajanca-Lavado M, Mamede R, et al.: Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023. Euro Surveill 2023; 28: 2300427.","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300427"},{"key":"10.3238\/arztebl.m2024.0127_ref16","doi-asserted-by":"crossref","unstructured":"Cobo-V\u00e1zquez E, Aguilera-Alonso D, Carrasco-Colom J, et al.: Increasing incidence and severity of invasive group A streptococcal disease in Spanish children in 2019–2022. Lancet Reg Heal Eur 2023; 27: 100597.","DOI":"10.1016\/j.lanepe.2023.100597"},{"key":"10.3238\/arztebl.m2024.0127_ref17","doi-asserted-by":"crossref","unstructured":"Bell\u00e9s-Bell\u00e9s A, Prim N, Mormeneo-Bayo S, et al.: Changes in group A Streptococcus emm types associated with invasive infections in adults, Spain, 2023. Emerg Infect Dis 2023; 29: 2390–2.","DOI":"10.3201\/eid2911.230857"},{"key":"10.3238\/arztebl.m2024.0127_ref18","doi-asserted-by":"crossref","unstructured":"van Kempen EB, Bruijning-Verhagen PCJ, Borensztajn D, et al.: Increase in invasive group a streptococcal infections in children in the Netherlands, a survey among 7 hospitals in 2022. Pediatr Infect Dis J 2023; 42: e122–4.","DOI":"10.1097\/INF.0000000000003810"},{"key":"10.3238\/arztebl.m2024.0127_ref19","doi-asserted-by":"crossref","unstructured":"van der Putten BCL, Bril-Keijzers WCM, Rumke LW, et al.: Novel emm4 lineage associated with an upsurge in invasive group A streptococcal disease in the Netherlands, 2022. Microb Genom 2023; 9: mgen001026.","DOI":"10.1099\/mgen.0.001026"},{"key":"10.3238\/arztebl.m2024.0127_ref20","doi-asserted-by":"crossref","unstructured":"van der Putten BCL, Vlaminckx BJM, De Gier B, Freudenburg-De Graaf W, Van Sorge NM: Group A streptococcal meningitis with the M1UK variant in the Netherlands. JAMA 2023; 329: 1791–2.","DOI":"10.1001\/jama.2023.5927"},{"key":"10.3238\/arztebl.m2024.0127_ref21","doi-asserted-by":"crossref","unstructured":"Guy R, Henderson KL, Coelho J, et al.: Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill 2023; 28: 2200942.","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942"},{"key":"10.3238\/arztebl.m2024.0127_ref22","doi-asserted-by":"crossref","unstructured":"Davies PJB, Russell CD, Morgan AR, et al.: Increase of severe pulmonary infections in adults caused by M1UK Streptococcus pyogenes, central Scotland, UK. Emerg Infect Dis 2023; 29: 1638–42.","DOI":"10.3201\/eid2908.230569"},{"key":"10.3238\/arztebl.m2024.0127_ref23","doi-asserted-by":"crossref","unstructured":"Im\u00f6hl M, van der Linden M, Reinert RR, Ritter K: Invasive group A streptococcal disease and association with varicella in Germany, 1996–2009. FEMS Immunol Med Microbiol 2011; 62: 101–9.","DOI":"10.1111\/j.1574-695X.2011.00788.x"},{"key":"10.3238\/arztebl.m2024.0127_ref24","doi-asserted-by":"crossref","unstructured":"Singer R, Abu Sin M, Tenenbaum T, et al.: The increase in invasive bacterial infections with respiratory transmission in Germany, 2022\/2023. Dtsch Arztebl Int 2024; 121: 114–20.","DOI":"10.3238\/arztebl.m2023.0261"},{"key":"10.3238\/arztebl.m2024.0127_ref25","doi-asserted-by":"crossref","unstructured":"Wolters M, Berinson B, Degel-Brossmann N, et al.: Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotype. Infection 2024; 52: 667–71.","DOI":"10.1007\/s15010-023-02137-1"},{"key":"10.3238\/arztebl.m2024.0127_ref26","doi-asserted-by":"crossref","unstructured":"Im\u00f6hl M, Fitzner C, Perniciaro S, Van Der Linden M: Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014. PLoS One 2017; 12: e0180757.","DOI":"10.1371\/journal.pone.0180757"},{"key":"10.3238\/arztebl.m2024.0127_ref27","doi-asserted-by":"crossref","unstructured":"Im\u00f6hl M, Van Der Linden M: Antimicrobial susceptibility of invasive Streptococcus pyogenes isolates in Germany during 2003–2013. PLoS One 2015; 10: e0137313.","DOI":"10.1371\/journal.pone.0137313"},{"key":"10.3238\/arztebl.m2024.0127_ref28","doi-asserted-by":"crossref","unstructured":"Silva-Costa C, Fri\u00e3es A, Ramirez M, Melo-Cristino J: Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies. Expert Rev Anti Infect Ther 2015; 13: 615–28.","DOI":"10.1586\/14787210.2015.1023292"},{"key":"10.3238\/arztebl.m2024.0127_ref29","doi-asserted-by":"crossref","unstructured":"Venkatesan P: Rise in group A streptococcal infections in England. Lancet Respir Med 2023; 11: e16.","DOI":"10.1016\/S2213-2600(22)00507-0"},{"key":"10.3238\/arztebl.m2024.0127_ref30","doi-asserted-by":"crossref","unstructured":"Lynskey NN, Jauneikaite E, Li HK, et al.: Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis 2019; 19: 1209–18.","DOI":"10.1016\/S1473-3099(19)30446-3"},{"key":"10.3238\/arztebl.m2024.0127_ref31","doi-asserted-by":"crossref","unstructured":"Rybak A, Levy C, Angoulvant F, et al.: Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France. JAMA Netw Open 2022; 5: e2218959.","DOI":"10.1001\/jamanetworkopen.2022.18959"},{"key":"10.3238\/arztebl.m2024.0127_ref32","doi-asserted-by":"crossref","unstructured":"Herrera AL, Huber VC, Chaussee MS: The association between invasive group A streptococcal diseases and viral respiratory tract infections. Front Microbiol 2016; 7: 342.","DOI":"10.3389\/fmicb.2016.00342"},{"key":"10.3238\/arztebl.m2024.0127_ref33","doi-asserted-by":"crossref","unstructured":"Okamoto S, Nagase S: Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus–group A Streptococcus superinfection. Microbiol Immunol 2018; 62: 141–9.","DOI":"10.1111\/1348-0421.12577"},{"key":"10.3238\/arztebl.m2024.0127_ref34","doi-asserted-by":"crossref","unstructured":"Cohen R, Ashman M, Taha MK, et al.: Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now 2021; 51: 418–23.","DOI":"10.1016\/j.idnow.2021.05.004"},{"key":"10.3238\/arztebl.m2024.0127_ref35","doi-asserted-by":"crossref","unstructured":"Abo YN, Oliver J, McMinn A, et al.: Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges. Lancet Reg Health West Pac 2023; 41: 100873.","DOI":"10.1016\/j.lanwpc.2023.100873"},{"key":"10.3238\/arztebl.m2024.0127_ref36","doi-asserted-by":"crossref","unstructured":"Luca-Harari B, Darenberg J, Neal S, et al.: Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2009; 47: 1155–65.","DOI":"10.1128\/JCM.02155-08"},{"key":"10.3238\/arztebl.m2024.0127_ref37","doi-asserted-by":"crossref","unstructured":"Jespersen MG, Lacey JA, Tong SYC, Davies MR: Global genomic epidemiology of Streptococcus pyogenes. Infect Genet Evol 2020; 86: 104609.","DOI":"10.1016\/j.meegid.2020.104609"},{"key":"10.3238\/arztebl.m2024.0127_ref38","doi-asserted-by":"crossref","unstructured":"R\u00fcmke LW, de Gier B, Vestjens SMT, et al.: Dominance of M1UK clade among Dutch M1 Streptococcus pyogenes. Lancet Infect Dis 2020; 20: 539–40.","DOI":"10.1016\/S1473-3099(20)30278-4"},{"key":"10.3238\/arztebl.m2024.0127_ref39","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM): Informationen zur Verf\u00fcgbarkeit von Antibiotikas\u00e4ften und Empfehlungen zur Abmilderung m\u00f6glicher Engp\u00e4sse—Stand: 07.12.2023. www.bfarm.de\/DE\/Arzneimittel\/Arzneimittelinformationen\/Lieferengpaesse\/Antibiotika.html (last accessed on 30 December 2023)."},{"key":"10.3238\/arztebl.m2024.0127_ref40","doi-asserted-by":"crossref","unstructured":"Ventura-Gabarr\u00f3 C, Leung VH, Vlahović-Palčevski V, Machowska A, Monnet DL, H\u00f6gberg LD: Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU\/EEA, 2022. Euro Surveill 2023; 28: 2300604.","DOI":"10.2807\/1560-7917.ES.2023.28.46.2300604"},{"key":"10.3238\/arztebl.m2024.0127_ref41","doi-asserted-by":"crossref","unstructured":"Parks T, Elliott K, Lamagni T, et al.: Elevated risk of invasive group A streptococcal disease and host genetic variation in the human leucocyte antigen locus. Genes Immun 2020; 21: 63–70.","DOI":"10.1038\/s41435-019-0082-z"},{"key":"10.3238\/arztebl.m2024.0127_ref42","doi-asserted-by":"crossref","unstructured":"Wahl RU, L\u00fctticken R, Stanzel S, van der Linden M, Reinert RR: Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996–2002: results from a voluntary laboratory surveillance system. Clin Microbiol Infect 2007; 13: 1173–8.","DOI":"10.1111\/j.1469-0691.2007.01821.x"},{"key":"10.3238\/arztebl.m2024.0127_ref43","doi-asserted-by":"crossref","unstructured":"Lynskey NN, Lawrenson RA, Sriskandan S: New understandings in Streptococcus pyogenes. Curr Opin Infect Dis 2011; 24: 196–202.","DOI":"10.1097\/QCO.0b013e3283458f7e"},{"key":"10.3238\/arztebl.m2024.0127_ref44","doi-asserted-by":"crossref","unstructured":"Bootsma MCJ, Ferguson NM: The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci USA 2007; 104: 7588–93.","DOI":"10.1073\/pnas.0611071104"},{"key":"10.3238\/arztebl.m2024.0127_ref45","doi-asserted-by":"crossref","unstructured":"Lenharo M: WHO declares end to COVID-19’s emergency phase. Nature 2023; DOI: 10.1038\/d41586–023–01559-z (online ahead of print).","DOI":"10.1038\/d41586-023-01559-z"},{"key":"10.3238\/arztebl.m2024.0127_ref46","doi-asserted-by":"crossref","unstructured":"Patel RA, Binns HJ, Shulman ST: Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. J Pediatr. 2004; 144: 68–74.","DOI":"10.1016\/j.jpeds.2003.10.025"},{"key":"10.3238\/arztebl.m2024.0127_ref47","doi-asserted-by":"crossref","unstructured":"Lannes-Costa PS, Oliveira JSS, Silva Santos G, Nagao PE: A current review of pathogenicity determinants of Streptococcus sp. J Appl Microbiol 2021; 131: 1600–20.","DOI":"10.1111\/jam.15090"},{"key":"10.3238\/arztebl.m2024.0127_ref48","doi-asserted-by":"crossref","unstructured":"Walker MJ, Barnett TC, McArthur JD, et al.: Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin Microbiol Rev 2014; 27: 264–301.","DOI":"10.1128\/CMR.00101-13"},{"key":"10.3238\/arztebl.m2024.0127_ref49","doi-asserted-by":"crossref","unstructured":"Metzgar D, Zampolli A: The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker. Virulence 2011; 2: 402–12.","DOI":"10.4161\/viru.2.5.16342"},{"key":"10.3238\/arztebl.m2024.0127_ref50","unstructured":"Boeddha NP, Atkins L, de Groot R, et al.: Group A streptococcal disease in paediatric inpatients: a European perspective. Eur J Pediatr 2023; 182: 697–706."},{"key":"10.3238\/arztebl.m2024.0127_ref51","doi-asserted-by":"crossref","unstructured":"Gale AH: A century of changes in the mortality and incidence of the principal infections of childhood. Arch Dis Child 1945; 20: 2–21.","DOI":"10.1136\/adc.20.101.2"},{"key":"10.3238\/arztebl.m2024.0127_ref52","doi-asserted-by":"crossref","unstructured":"Gaworzewska E, Colman G: Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect 1988; 100: 257–69.","DOI":"10.1017\/S095026880006739X"},{"key":"10.3238\/arztebl.m2024.0127_ref53","doi-asserted-by":"crossref","unstructured":"Lamagni T, Guy R, Chand M, et al.: Resurgence of scarlet fever in England, 2014–16: a population-based surveillance study. Lancet Infect Dis 2018; 18: 180–7.","DOI":"10.1016\/S1473-3099(17)30693-X"},{"key":"10.3238\/arztebl.m2024.0127_ref54","doi-asserted-by":"crossref","unstructured":"Avire NJ, Whiley H, Ross K: A review of Streptococcus pyogenes: public health risk factors, prevention and control. Pathogens 2021; 10: 248.","DOI":"10.3390\/pathogens10020248"},{"key":"10.3238\/arztebl.m2024.0127_ref55","doi-asserted-by":"crossref","unstructured":"Brouwer S, Rivera-Hernandez T, Curren BF, et al.: Pathogenesis, epidemiology and control of group A Streptococcus infection. Nat Rev Microbiol 2023; 21: 431–47.","DOI":"10.1038\/s41579-023-00865-7"},{"key":"10.3238\/arztebl.m2024.0127_ref56","doi-asserted-by":"crossref","unstructured":"Commons RJ, Smeesters PR, Proft T, Fraser JD, Robins-Browne R, Curtis N: Streptococcal superantigens: categorization and clinical associations. Trends Mol Med 2014; 20: 48–62.","DOI":"10.1016\/j.molmed.2013.10.004"},{"key":"10.3238\/arztebl.m2024.0127_ref57","doi-asserted-by":"crossref","unstructured":"Li HK, Zhi X, Vieira A, et al.: Characterization of emergent toxigenic M1UK Streptococcus pyogenes and associated sublineages. Microb Genom 2023; 9: mgen000994.","DOI":"10.1099\/mgen.0.000994"},{"key":"10.3238\/arztebl.m2024.0127_ref58","doi-asserted-by":"crossref","unstructured":"Yu D, Guo D, Zheng Y, Yang Y: A review of penicillin binding protein and group A Streptococcus with reduced-β-lactam susceptibility. Front Cell Infect Microbiol 2023; 13: 1117160.","DOI":"10.3389\/fcimb.2023.1117160"},{"key":"10.3238\/arztebl.m2024.0127_ref59","doi-asserted-by":"crossref","unstructured":"Carapetis JR, Jacoby P, Carville K, Ang SJJ, Curtis N, Andrews R: Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections. Clin Infect Dis 2014; 59: 358–65.","DOI":"10.1093\/cid\/ciu304"},{"key":"10.3238\/arztebl.m2024.0127_ref60","doi-asserted-by":"crossref","unstructured":"Johnson AF, LaRock CN: Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by group A Streptococcus. Front Microbiol 2021; 12: 760255.","DOI":"10.3389\/fmicb.2021.760255"},{"key":"10.3238\/arztebl.m2024.0127_ref61","doi-asserted-by":"crossref","unstructured":"Miller KM, Lamagni T, Cherian T, et al.: Standardization of epidemiological surveillance of invasive group A streptococcal infections. Open Forum Infect Dis 2022; 9: S31–40.","DOI":"10.1093\/ofid\/ofac281"},{"key":"10.3238\/arztebl.m2024.0127_ref62","unstructured":"Institut f\u00fcr medizinische Mikorbiologie: Referenzlabor f\u00fcr Streptokokken: www.ukaachen.de\/kliniken-institute\/institut-fuer-medizinische-mikrobiologie\/forschung\/nationales-referenzzentrum-fuer-streptokokken\/ (last accessed on 10 June 2024)."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:04:34Z","timestamp":1727345074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":62,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0127","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]}}}